Pharmacologic lowering of prion protein (PrP) delays onset and slows progression of prion disease in animal models1–3, consistent with PrP as the substrate for prion misfolding and the pivotal molecule in progression of this rapid neurodegenerative disease4,5. This evidence concerns the gene PRNP and prion disease.